Gizmodo: Makers of Ozempic and Mounjaro Sued Over Allegedly 'Downplaying' Severe Side Effects https://gizmodo.com/makers-ozempic-mounjaro-sued-downplay-side-effects-1850704899 #glucagonlikepeptide1receptoragonist #antiobesitymedication #glucagonlikepeptide1 #healthmedicalpharma #elilillyandcompany #jaclynbjorklund #peptidehormones #gastroparesis #tirzepatide #semaglutide #novonordisk #elililly #diabetes
#glucagonlikepeptide1receptoragonist #antiobesitymedication #glucagonlikepeptide1 #healthmedicalpharma #elilillyandcompany #jaclynbjorklund #peptidehormones #gastroparesis #tirzepatide #semaglutide #novonordisk #elililly #diabetes
#EliLilly expects #FDA approval of its #Alzheimers drug this year
A second drug that modestly slows the progression of Alzheimer's disease could be approved by the end of this year, manufacturer Eli Lilly said Monday.
#HealthCare #MentalHealth
https://thehill.com/policy/healthcare/4101620-eli-lilly-expects-fda-approval-of-its-alzheimers-drug-this-year/
#elililly #fda #alzheimers #healthcare #mentalhealth
Ars Technica: Eli Lilly drug shown to slow Alzheimer’s progression https://arstechnica.com/?p=1954453 #Tech #arstechnica #IT #Technology #Alzheimer'sdisease #Alzheimer'sdrug #Alzheimer's #syndication #dementia #elililly #Science #Health
#Tech #arstechnica #it #technology #alzheimer #syndication #dementia #elililly #science #health
#Datreveno #EliLilly #Farmacio
Je ĉi dato en 1838 naskiĝis Eli Lilly, farmaciisto, kiu fondis sukcesan aferon vendi kemiaĵojn al farmaciistoj. Li konvinkis la registaron krei instancon kiu regis la farmacian industrion kaj plifortigi kontrolon de kvalito. Li ankaŭ kreis la nocion recepto por kuraciloj. https://en.wikipedia.org/wiki/Eli_Lilly
Bildo: https://commons.wikimedia.org/wiki/File:Colonel_eli_lilly_in_1885-enhanced.jpg
#datreveno #elililly #farmacio
Eli Lilly restarts 'limited' Twitter posting and advertising, continues to assess social media strategy
https://www.fiercepharma.com/marketing/eli-lilly-restarts-limited-twitter-posting-and-advertising-continues-assess-social-media
#Twitter #elililly #socialmedia #pharma
Lilly drug slows Alzheimer’s decline in large study —FDA encourages decentralized trials with new guidance — Masimo suit against Apple over smartwatch trade secrets ends in mistrial -- See more on our front page news http://bit.ly/w28kSd #alzheimers #fda #elililly #clinicaltrials #legal #apple #masimo #tradesecrets #smartwatch #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#alzheimers #FdA #elililly #clinicaltrials #legal #apple #masimo #tradesecrets #smartwatch #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too —FDA sent letter to HCPs warning of cybersecurity risk in Illumina sequencing software—GSK's RSV vaccine first to get EU regulator's nod -- See more on our front page news http://bit.ly/w28kSd #fda #amgen #lupus #elililly #hcps #cybersecurity #illumina #rsv #gsk #europe #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #amgen #lupus #elililly #HCPs #cybersecurity #illumina #RSV #gsk #europe #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA approves first oral microbiome therapy Vowst —EU publishes proposed drug laws overhaul, setting up tussle with industry—Lilly drug Mounjaro succeeds in second weight loss study -- See more on our front page news http://bit.ly/w28kSd #fda #microbiome #eu #europe #pharmaindustry #elililly #obesity #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #microbiome #eu #europe #pharmaindustry #elililly #obesity #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Big Pharma’s R&D spending flatlined in 2022: What it means for the industry —Bluebird Bio submits BLA for sickle cell disease gene therapy—Eli Lilly launches Mounjaro head-to-head trial against Novo Nordisk's Wegovy-- See more on our front page news http://bit.ly/w28kSd #bigpharma #researchanddevelopment #bluebirdbio #sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#bigpharma #researchanddevelopment #bluebirdbio #Sicklecelldisease #genetherapy #obesity #elililly #novonordisk #wegovy #mounjaro #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs —Boehringer taps RetinAI for AI boost to eye disease R&D—Big pharma holds steady on research spending-- See more on our front page news http://bit.ly/w28kSd #researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#researchanddevelopment #artificialintelligence #ai #bigpharma #boehringeringelheim #elililly #medicare #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA approves Keytruda/Padcev combo in advanced urothelial cancer — Record growth in U.S. life sciences real estate footprint — Diabesity drugs and their free ‘contract sales force’ -- See more on our front page news http://bit.ly/w28kSd #fda #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #merck #astellas #urothelialcancer #realestate #diabetes #obesity #novonordisk #elililly #keytruda #lifesciences #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail — Lilly says experimental Alzheimer's drug reduces amyloid in small study — BioNTech, DualityBio to develop cancer treatment drugs in over $1.5-bln deal -- See more on our front page news http://bit.ly/w28kSd #ftc #mergersandacquisitions #competition #illumina #alzheimers #elililly #cancer #drugdevelopment #biontech #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FTC #mergersandacquisitions #Competition #illumina #alzheimers #elililly #cancer #drugdevelopment #biontech #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi — Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test— Boston Scientific, Medtronic expected to quickly capture new atrial fibrillation market -- See more on our front page news http://bit.ly/w28kSd #pfizer #astellas #prostatecancer #roche #elililly #diagnostics #medtech #alzheimers #atrialfibrillation #afib #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#pfizer #astellas #ProstateCancer #roche #elililly #diagnostics #medtech #alzheimers #AtrialFibrillation #afib #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
Here’s why slashing insulin prices will actually save Big Pharma money - Enlarge / In this photo illustration, insulin pens manufactured by Nov... - https://arstechnica.com/?p=1924105 #pharmaceuticalindustry #novonordisk #bigpharma #elililly #medicaid #medicare #science #insulin #rebates
#rebates #insulin #science #medicare #medicaid #elililly #bigpharma #novonordisk #pharmaceuticalindustry
Ars Technica: Here’s why slashing insulin prices will actually save Big Pharma money https://arstechnica.com/?p=1924105 #Tech #arstechnica #IT #Technology #Pharmaceuticalindustry #NovoNordisk #Bigpharma #elililly #medicaid #Medicare #Science #insulin #rebates
#Tech #arstechnica #it #technology #pharmaceuticalindustry #novonordisk #bigpharma #elililly #medicaid #medicare #science #insulin #rebates
Lilly’s Alzheimer’s struggles continue as preclinical asset fails phase III— AstraZeneca says cancer drug Imfinzi improves survival chances in late-stage trial — Bayer plans to double down on US pharma R&D in 2023-- See more on our front page news http://bit.ly/w28kSd #elililly #astrazeneca #alzheimers #clinicaltrials #researchanddevelopment #bayer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#elililly #astrazeneca #alzheimers #clinicaltrials #researchanddevelopment #Bayer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
FDA sets July decision date for full approval of Leqembi — FDA widens Lilly's Verzenio breast cancer reach — Praxis shares fall 48% following mixed data for essential tremor candidate-- See more on our front page news http://bit.ly/w28kSd #fda #alzheimers #eisai #biogen #elililly #breastcancer #essentialtremor #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
#FdA #alzheimers #eisai #biogen #elililly #breastcancer #essentialtremor #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
In case you missed it, #EliLilly has agreed to cap the monthly cost of insulin to USD$35: